ACE2-IgG1 fusions with improved in vitro and in vivo activity against SARS-CoV-2

These are raw data for figures in ACE2-IgG1 fusions with improved in vitro and in vivo activity against SARS-CoV-2, in iScience: PMID: 34957381本数据集系发表于《iScience》期刊、PubMed编号34957381的研究论文配图的原始数据，该论文所研究的ACE2-IgG1融合蛋白（ACE2-IgG1 fusions）具备增强的体外（in vitro）与体内（in vivo）抗严重急性呼吸综合征冠状病毒2（SARS-CoV-2）活性。